{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T20:20:57Z","timestamp":1789158057962,"version":"build-2803163510"},"reference-count":179,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T00:00:00Z","timestamp":1667347200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>\n                    Primary membranous nephropathy (PMN) is one of the common causes of adult-onset nephrotic syndrome and is characterized by autoantibodies against podocyte antigens causing\n                    <jats:italic>in situ<\/jats:italic>\n                    immune complex deposition. Much of our understanding of the disease mechanisms underpinning this kidney-limited autoimmune disease originally came from studies of Heymann nephritis, a rat model of PMN, where autoantibodies against megalin produced a similar disease phenotype though megalin is not implicated in human disease. In PMN, the major target antigen was identified to be M-type phospholipase A2 receptor 1 (PLA2R) in 2009. Further utilization of mass spectrometry on immunoprecipitated glomerular extracts and laser micro dissected glomeruli has allowed the rapid discovery of other antigens (thrombospondin type-1 domain-containing protein 7A, neural epidermal growth factor-like 1 protein, semaphorin 3B, protocadherin 7, high temperature requirement A serine peptidase 1, netrin G1) targeted by autoantibodies in PMN. Despite these major advances in our understanding of the pathophysiology of PMN, treatments remain non-specific, often ineffective, or toxic. In this review, we summarize our current understanding of the immune mechanisms driving PMN from animal models and clinical studies, and the implications on the development of future targeted therapeutic strategies.\n                  <\/jats:p>","DOI":"10.3389\/fimmu.2022.1036249","type":"journal-article","created":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T10:12:16Z","timestamp":1667383936000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":28,"title":["Membranous nephropathy: Clearer pathology and mechanisms identify potential strategies for treatment"],"prefix":"10.3389","volume":"13","author":[{"given":"Edmund Y. M.","family":"Chung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan M.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Keung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugh","family":"McCarthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Germaine","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"Kairaitis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhadran","family":"Bose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C. H.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen I.","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,11,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"983","DOI":"10.2215\/CJN.11761116","article-title":"Primary membranous nephropathy","volume":"12","author":"Couser","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1146\/annurev-pathol-020117-043811","article-title":"Molecular pathogenesis of membranous nephropathy","volume":"15","author":"Ronco","year":"2020","journal-title":"Annu Rev Pathol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa0810457","article-title":"M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy","volume":"361","author":"Beck","year":"2009","journal-title":"N Engl J Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1409354","article-title":"Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy","volume":"371","author":"Tomas","year":"2014","journal-title":"N Engl J Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"e104936","DOI":"10.1371\/journal.pone.0104936","article-title":"The diagnosis accuracy of PLA2R-AB in the diagnosis of idiopathic membranous nephropathy: a meta-analysis","volume":"9","author":"Du","year":"2014","journal-title":"PloS One"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198404123101503","article-title":"Controlled trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy","volume":"310","author":"Ponticelli","year":"1984","journal-title":"N Engl J Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1056\/NEJM198901053200102","article-title":"A randomized trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy","volume":"320","author":"Ponticelli","year":"1989","journal-title":"N Engl J Med"},{"key":"B8","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1056\/NEJM199208273270904","article-title":"Methylprednisolone plus chlorambucil as compared with methylprednisolone alone for the treatment of idiopathic membranous nephropathy. the Italian idiopathic membranous nephropathy treatment study group","volume":"327","author":"Ponticelli","year":"1992","journal-title":"N Engl J Med"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V93444","article-title":"A randomized study comparing methylprednisolone plus chlorambucil versus methylprednisolone plus cyclophosphamide in idiopathic membranous nephropathy","volume":"9","author":"Ponticelli","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2007020166","article-title":"A randomized, controlled trial of steroids and cyclophosphamide in adults with nephrotic syndrome caused by idiopathic membranous nephropathy","volume":"18","author":"Jha","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2001.0590041484.x","article-title":"Cyclosporine in patients with steroid-resistant membranous nephropathy: a randomized trial","volume":"59","author":"Cattran","year":"2001","journal-title":"Kidney Int"},{"key":"B12","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1056\/NEJMoa1814427","article-title":"Rituximab or cyclosporine in the treatment of membranous nephropathy","volume":"381","author":"Fervenza","year":"2019","journal-title":"N Engl J Med"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2017.92","article-title":"Treatment of membranous nephropathy: time for a paradigm shift","volume":"13","author":"Ruggenenti","year":"2017","journal-title":"Nat Rev Nephrol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2020.10.014","article-title":"The STARMEN trial indicates that alternating treatment with corticosteroids and cyclophosphamide is superior to sequential treatment with tacrolimus and rituximab in primary membranous nephropathy","volume":"99","author":"Fern\u00e1ndez-Ju\u00e1rez","year":"2021","journal-title":"Kidney Int"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2020071091","article-title":"Rituximab or cyclophosphamide in the treatment of membranous nephropathy: The RI-CYCLO randomized trial","volume":"32","author":"Scolari","year":"2021","journal-title":"J Am Soc Nephrol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000001056","article-title":"Recurrent membranous nephropathy after kidney transplantation: Treatment and long-term implications","volume":"100","author":"Grupper","year":"2016","journal-title":"Transplantation"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1003066","article-title":"PLA2R autoantibodies and recurrent membranous nephropathy after transplantation","volume":"363","author":"Stahl","year":"2010","journal-title":"N Engl J Med"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2008.02237.x","article-title":"Recurrent idiopathic membranous nephropathy after kidney transplantation: a surveillance biopsy study","volume":"8","author":"Dabade","year":"2008","journal-title":"Am J Transpl"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfq223","article-title":"Long-term outcome of renal transplantation in patients with idiopathic membranous glomerulonephritis (MN)","volume":"25","author":"Moroni","year":"2010","journal-title":"Nephrol Dial Transpl"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.603237","article-title":"Chimeric antigen receptor based therapy as a potential approach in autoimmune diseases: How close are we to the treatment","volume":"11","author":"Sadeqi Nezhad","year":"2020","journal-title":"Front Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3181\/00379727-100-24736","article-title":"Production of nephrotic syndrome in rats by freund\u2019s adjuvants and rat kidney suspensions","volume":"100","author":"Heymann","year":"1959","journal-title":"Proc Soc Exp Biol Med"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1172\/JCI109248","article-title":"Experimental glomerulonephritis in the isolated perfused rat kidney","volume":"62","author":"Couser","year":"1978","journal-title":"J Clin Invest"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1984.225","article-title":"Detection of terminal complement components in experimental immune glomerular injury","volume":"26","author":"Adler","year":"1984","journal-title":"Kidney Int"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2019.10.022","article-title":"A novel mouse model of phospholipase A2 receptor 1-associated membranous nephropathy mimics podocyte injury in patients","volume":"97","author":"Meyer-Schwesinger","year":"2020","journal-title":"Kidney Int"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1172\/JCI85265","article-title":"Autoantibodies against thrombospondin type 1 domain\u2013containing 7A induce membranous nephropathy","volume":"126","author":"Tomas","year":"2016","journal-title":"J Clin Invest"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20180131","article-title":"Human anti-thrombospondin type 1 domain-containing 7A antibodies induce membranous nephropathy through activation of lectin complement pathway","volume":"38","author":"Wang","year":"2018","journal-title":"Biosci Rep"},{"key":"B27","doi-asserted-by":"publisher","first-page":"3262","DOI":"10.1681\/ASN.2017010030","article-title":"A heterologous model of thrombospondin type 1 domain-containing 7A-associated membranous nephropathy","volume":"28","author":"Tomas","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2022.09.008","article-title":"Podocyte expression of human phospholipase A2 receptor 1 causes immune-mediated membranous nephropathy in mice","author":"Tomas","year":"2022","journal-title":"Kidney Int"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1084\/jem.175.3.623","article-title":"A nephritogenic rat monoclonal antibody to mouse aminopeptidase a. induction of massive albuminuria after a single intravenous injection","volume":"175","author":"Assmann","year":"1992","journal-title":"J Exp Med"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1159\/000072026","article-title":"Podocyte changes after induction of acute albuminuria in mice by anti-aminopeptidase a mAb","volume":"94","author":"Dijkman","year":"2003","journal-title":"Nephron Exp Nephrol"},{"key":"B31","first-page":"434","article-title":"Identification of gp108, a pathogenic antigen of passive heymann nephritis, as dipeptidyl peptidase IV","volume":"70","author":"Natori","year":"1987","journal-title":"Clin Exp Immunol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1003451","article-title":"Nephrotic syndrome and subepithelial deposits in a mouse model of immune-mediated anti-podocyte glomerulonephritis","volume":"187","author":"Meyer-Schwesinger","year":"2011","journal-title":"J Immunol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5002450","article-title":"A new mouse model of immune-mediated podocyte injury","volume":"72","author":"Meyer","year":"2007","journal-title":"Kidney Int"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1172\/JCI110469","article-title":"Induction of membranous nephropathy in rabbits by administration of an exogenous cationic antigen: Demonstration of a pathogenic role for electrical charge","volume":"69","author":"Border","year":"1982","journal-title":"J Clin Invest"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1103368","article-title":"Murine membranous nephropathy: Immunization with \u03b13 (IV) collagen fragment induces subepithelial immune complexes and Fc\u03b3R-independent nephrotic syndrome","volume":"188","author":"Zhang","year":"2012","journal-title":"J Immunol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.kint.2021.03.028","article-title":"A conceptual framework linking immunology, pathology, and clinical features in primary membranous nephropathy","volume":"100","author":"Lerner","year":"2021","journal-title":"Kidney Int"},{"key":"B37","first-page":"500","article-title":"Ultrastructural localization by monoclonal antibodies of brush border antigens expressed by glomeruli. i. renal distribution","volume":"122","author":"Chatelet","year":"1986","journal-title":"Am J Pathol"},{"key":"B38","first-page":"512","article-title":"Ultrastructural localization by monoclonal antibodies of brush border antigens expressed by glomeruli. II. extrarenal distribution","volume":"122","author":"Chatelet","year":"1986","journal-title":"Am J Pathol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1177\/42.4.7510321","article-title":"Organ distribution in rats of two members of the low-density lipoprotein receptor gene family, gp330 and LRP\/alpha 2MR, and the receptor-associated protein (RAP)","volume":"42","author":"Zheng","year":"1994","journal-title":"J Histochem Cytochem"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2019.09.014","article-title":"Neural epidermal growth factor-like 1 protein (NELL-1) associated membranous nephropathy","volume":"97","author":"Sethi","year":"2020","journal-title":"Kidney Int"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2020.05.030","article-title":"Semaphorin 3B-associated membranous nephropathy is a distinct type of disease predominantly present in pediatric patients","volume":"98","author":"Sethi","year":"2020","journal-title":"Kidney Int"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5000313","article-title":"Autocrine class 3 semaphorin system regulates slit diaphragm proteins and podocyte survival","volume":"69","author":"Guan","year":"2006","journal-title":"Kidney Int"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2020081165","article-title":"Hematopoietic Stem Cell Transplant-Membranous Nephropathy Is Associated with Protocadherin FAT1","volume":"33","author":"Sethi","year":"2022","journal-title":"J Am Soc Nephrol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2020101395","article-title":"Serine protease HTRA1 as a novel target antigen in primary membranous nephropathy","volume":"32","author":"Al-Rabadi","year":"2021","journal-title":"J Am Soc Nephrol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2022050608","article-title":"Netrin G1 is a novel target antigen in primary membranous nephropathy","volume":"33","author":"Reinhard","year":"2022","journal-title":"J Am Soc Nephrol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1681\/ASN.2018080852","article-title":"Exostosin 1\/Exostosin 2\u2013associated membranous nephropathy","volume":"30","author":"Sethi","year":"2019","journal-title":"J Am Soc Nephrol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2020.09.016","article-title":"Neural cell adhesion molecule 1 is a novel autoantigen in membranous lupus nephritis","volume":"100","author":"Caza","year":"2020","journal-title":"Kidney Int"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.34067\/KID.0001492021","article-title":"Transforming growth factor beta receptor 3 (TGFBR3)-associated membranous nephropathy","volume":"2","author":"Caza","year":"2021","journal-title":"Kidney360"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2021.08.014","article-title":"Contactin-1 is a novel target antigen in membranous nephropathy associated with chronic inflammatory demyelinating polyneuropathy","volume":"100","author":"Le Quintrec","year":"2021","journal-title":"Kidney Int"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2021111488","article-title":"Hematopoietic stem cell transplant-membranous nephropathy is associated with protocadherin FAT1","volume":"33","author":"Sethi","year":"2022","journal-title":"J Am Soc Nephrol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa012895","article-title":"Antenatal membranous glomerulonephritis due to anti-neutral endopeptidase antibodies","volume":"346","author":"Debiec","year":"2002","journal-title":"N Engl J Med"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.22252","article-title":"Expression of neutral endopeptidase (NEP\/CD10) on pancreatic tumor cell lines, pancreatitis and pancreatic tumor tissues","volume":"120","author":"Erhuma","year":"2007","journal-title":"Int J Cancer"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1084\/jem.127.3.555","article-title":"Autologous immune complex nephritix induced with renal tubular antigen: I. identification and isolation of the pathogenic antigen","volume":"127","author":"Edgington","year":"1968","journal-title":"J Exp Med"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.79.18.5557","article-title":"The pathogenic antigen of heymann nephritis is a membrane glycoprotein of the renal proximal tubule brush border","volume":"79","author":"Kerjaschki","year":"1982","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B55","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1681\/ASN.V6135","article-title":"The heymann nephritis antigenic complex: megalin (gp330) and RAP","volume":"6","author":"Farquhar","year":"1995","journal-title":"J Am Soc Nephrol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"104537","DOI":"10.1016\/j.phrs.2019.104537","article-title":"Megalin: a bridge connecting kidney, the renin-angiotensin system, and atherosclerosis","volume":"151","author":"Kukida","year":"2020","journal-title":"Pharmacol Res"},{"key":"B57","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.142.9.3145","article-title":"A matched set of rat\/mouse chimeric antibodies. identification and biological properties of rat h chain constant regions mu, gamma 1, gamma 2a, gamma 2b, gamma 2c, epsilon, and alpha","volume":"142","author":"Br\u00fcggemann","year":"1989","journal-title":"J Immunol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/0090-1229(84)90059-X","article-title":"Factors influencing susceptibility of LEW rats to heymann nephritis","volume":"30","author":"Noble","year":"1984","journal-title":"Clin Immunol Immunopathol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1084\/jem.188.10.1775","article-title":"Permanent CD8+ T cell depletion prevents proteinuria in active heymann nephritis","volume":"188","author":"Penny","year":"1998","journal-title":"J Exp Med"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2007030342","article-title":"Intramolecular epitope spreading in heymann nephritis","volume":"18","author":"Shah","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.4049\/jimmunol.172.4.2367","article-title":"Conformation and glycosylation of a megalin fragment correlate with nephritogenicity in heymann nephritis","volume":"172","author":"Tramontano","year":"2004","journal-title":"J Immunol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1681\/ASN.2014050502","article-title":"Identification of a major epitope recognized by PLA2R autoantibodies in primary membranous nephropathy","volume":"26","author":"Fresquet","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"102308","DOI":"10.1016\/j.jaut.2019.102308","article-title":"Autoantigens PLA2R and THSD7A in membranous nephropathy share a common epitope motif in the n-terminal domain","volume":"106","author":"Fresquet","year":"2020","journal-title":"J Autoimmun"},{"key":"B64","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1681\/ASN.2019030273","article-title":"Clinical relevance of domain-specific phospholipase A(2) receptor 1 antibody levels in patients with membranous nephropathy","volume":"31","author":"Reinhard","year":"2020","journal-title":"J Am Soc Nephrol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfz171","article-title":"Megalin\/lipoprotein receptor-related protein 2 autoimmunity and kidney disease","volume":"13","author":"Perez-Gomez","year":"2020","journal-title":"Clin Kidney J"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2017060664","article-title":"LDL receptor-related protein 2 (Megalin) as a target antigen in human kidney anti-brush border antibody disease","volume":"29","author":"Larsen","year":"2018","journal-title":"J Am Soc Nephrol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.07210810","article-title":"Anti-phospholipase A2 receptor antibodies correlate with clinical status in idiopathic membranous nephropathy","volume":"6","author":"Hofstra","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-020-02588-7","article-title":"The association of anti-PLA2R with clinical manifestations and outcomes in idiopathic membranous nephropathy: a meta-analysis","volume":"52","author":"Rao","year":"2020","journal-title":"Int Urol Nephrol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1681\/ASN.2014070640","article-title":"Anti-phospholipase A2 receptor antibody titer predicts post-rituximab outcome of membranous nephropathy","volume":"26","author":"Ruggenenti","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1172\/JCI140453","article-title":"Altered glycosylation of IgG4 promotes lectin complement pathway activation in anti-PLA2R1\u2013associated membranous nephropathy","volume":"131","author":"Haddad","year":"2021","journal-title":"J Clin Invest"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2202209119","article-title":"Structure of PLA2R reveals presentation of the dominant membranous nephropathy epitope and an immunogenic patch","volume":"119","author":"Fresquet","year":"2022","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B72","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1681\/ASN.2017070734","article-title":"Phospholipase A2 receptor 1 epitope spreading at baseline predicts reduced likelihood of remission of membranous nephropathy","volume":"29","author":"Seitz-Polski","year":"2018","journal-title":"J Am Soc Nephrol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1681\/ASN.2014111061","article-title":"Epitope spreading of autoantibody response to PLA2R associates with poor prognosis in membranous nephropathy","volume":"27","author":"Seitz-Polski","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1009742","article-title":"Risk HLA-DQA1 and PLA(2)R1 alleles in idiopathic membranous nephropathy","volume":"364","author":"Stanescu","year":"2011","journal-title":"N Engl J Med"},{"key":"B75","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1038\/s41467-020-15383-w","article-title":"The genetic architecture of membranous nephropathy and its potential to improve non-invasive diagnosis","volume":"11","author":"Xie","year":"2020","journal-title":"Nat Commun"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2016020114","article-title":"MHC class II risk alleles and amino acid residues in idiopathic membranous nephropathy","volume":"28","author":"Cui","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2011.03643.x","article-title":"Autoantibodies specific for the phospholipase A2 receptor in recurrent and de novo membranous nephropathy","volume":"11","author":"Debiec","year":"2011","journal-title":"Am J Transpl"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.13133","article-title":"Anti-phospholipase A2 receptor antibodies in recurrent membranous nephropathy","volume":"15","author":"Kattah","year":"2015","journal-title":"Am J Transpl"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000000630","article-title":"Antiphospholipase A2 receptor antibody levels predict the risk of posttransplantation recurrence of membranous nephropathy","volume":"99","author":"Quintana","year":"2015","journal-title":"Transplantation"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2020.08.007","article-title":"HLA-d and PLA2R1 risk alleles associate with recurrent primary membranous nephropathy in kidney transplant recipients","volume":"99","author":"Berchtold","year":"2021","journal-title":"Kidney Int"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2020.01.009","article-title":"Association of HLA typing and alloimmunity with posttransplantation membranous nephropathy: A multicenter case series","volume":"76","author":"Batal","year":"2020","journal-title":"Am J Kidney Dis"},{"key":"B82","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1681\/ASN.2017070805","article-title":"The most n-terminal region of THSD7A is the predominant target for autoimmunity in THSD7A-associated membranous nephropathy","volume":"29","author":"Seifert","year":"2018","journal-title":"J Am Soc Nephrol"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2016.32","article-title":"THSD7A staining of membranous glomerulopathy in clinical practice reveals cases with dual autoantibody positivity","volume":"29","author":"Larsen","year":"2016","journal-title":"Mod Pathol"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2021101323","article-title":"Recurrence of anti-semaphorin 3B-mediated membranous nephropathy after kidney transplantation","volume":"33","author":"Fila","year":"2022","journal-title":"J Am Soc Nephrol"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2020071082","article-title":"New \u2018Antigens\u2019 in membranous nephropathy","volume":"32","author":"Sethi","year":"2021","journal-title":"J Am Soc Nephrol"},{"key":"B86","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1681\/ASN.2020081181","article-title":"In patients with membranous lupus nephritis, exostosin-positivity and exostosin-negativity represent two different phenotypes","volume":"32","author":"Ravindran","year":"2021","journal-title":"J Am Soc Nephrol"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1159\/000431331","article-title":"Renal phospholipase A2 receptor in hepatitis b virus-associated membranous nephropathy","volume":"41","author":"Xie","year":"2015","journal-title":"Am J Nephrol"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1511702","article-title":"A mechanism for cancer-associated membranous nephropathy","volume":"374","author":"Hoxha","year":"2016","journal-title":"N Engl J Med"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2016010050","article-title":"An indirect immunofluorescence method facilitates detection of thrombospondin type 1 domain-containing 7A-specific antibodies in membranous nephropathy","volume":"28","author":"Hoxha","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2020.07.039","article-title":"NELL1 is a target antigen in malignancy-associated membranous nephropathy","volume":"99","author":"Caza","year":"2021","journal-title":"Kidney Int"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)17142-0","article-title":"Role of truncating mutations in MME gene in fetomaternal alloimmunisation and antenatal glomerulopathies","volume":"364","author":"Debiec","year":"2004","journal-title":"Lancet"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2008121259","article-title":"Autoimmunity in membranous nephropathy targets aldose reductase and SOD2","volume":"21","author":"Prunotto","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.02170312","article-title":"Coexistence of different circulating anti-podocyte antibodies in membranous nephropathy","volume":"7","author":"Murtas","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"B94","doi-asserted-by":"publisher","first-page":"13659","DOI":"10.1038\/s41598-022-17696-w","article-title":"Discovery of anti-formin-like 1 protein (FMNL1) antibodies in membranous nephropathy and other glomerular diseases","volume":"12","author":"Bruschi","year":"2022","journal-title":"Sci Rep"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/4.4.423","article-title":"The role of T cells in the mediation of glomerular injury in heymann\u2019s nephritis in the rat","volume":"4","author":"Quiza","year":"1992","journal-title":"Int Immunol"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1997.148","article-title":"Role of T cells in the mediation of heymann nephritis. ii. identification of Th1 and cytotoxic cells in glomeruli","volume":"51","author":"Penny","year":"1997","journal-title":"Kidney Int"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.179.1.172","article-title":"Induction of passive heymann nephritis in complement component 6-deficient PVG rats","volume":"179","author":"Spicer","year":"2007","journal-title":"J Immunol"},{"key":"B98","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1681\/ASN.2011090914","article-title":"CD8+ regulatory T cells induced by T cell vaccination protect against autoimmune nephritis","volume":"23","author":"Wang","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"B99","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/0008-8749(86)90264-9","article-title":"Reestablishment of self tolerance by suppressor T-cells after active heymann\u2019s nephritis","volume":"98","author":"de Heer","year":"1986","journal-title":"Cell Immunol"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1016\/0008-8749(85)90007-3","article-title":"The autoimmune response in active heymann\u2019s nephritis in Lewis rats is regulated by T-lymphocyte subsets","volume":"92","author":"de Heer","year":"1985","journal-title":"Cell Immunol"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2020.07.028","article-title":"A comprehensive phenotypic and functional immune analysis unravels circulating anti-phospholipase A2 receptor antibody secreting cells in membranous nephropathy patients","volume":"5","author":"Cantarelli","year":"2020","journal-title":"Kidney Int Rep"},{"key":"B102","doi-asserted-by":"publisher","first-page":"8190","DOI":"10.1038\/s41598-020-64863-y","article-title":"Generation of a conditional transgenic mouse model expressing human phospholipase A2 receptor 1","volume":"10","author":"Jaber","year":"2020","journal-title":"Sci Rep"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2005.00415.x","article-title":"Th2 cytokines increase and stimulate b cells to produce IgG4 in idiopathic membranous nephropathy","volume":"68","author":"Kuroki","year":"2005","journal-title":"Kidney Int"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2017.01.012","article-title":"B- and T-cell subpopulations in patients with severe idiopathic membranous nephropathy may predict an early response to rituximab","volume":"92","author":"Rosenzwajg","year":"2017","journal-title":"Kidney Int"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfg572","article-title":"Up-regulated interleukin-4 production by peripheral T-helper cells in idiopathic membranous nephropathy","volume":"19","author":"Masutani","year":"2004","journal-title":"Nephrol Dial Transpl"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1111\/1440-1681.12555","article-title":"Increased ratio of ICOS+\/PD-1+ follicular helper T cells positively correlates with the development of human idiopathic membranous nephropathy","volume":"43","author":"Shi","year":"2016","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1080\/08916934.2017.1385775","article-title":"Higher frequencies of circulating ICOS+, IL-21+ T follicular helper cells and plasma cells in patients with new-onset membranous nephropathy","volume":"50","author":"Zhang","year":"2017","journal-title":"Autoimmunity"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1159\/000058401","article-title":"Predominance of type-2 immune response in idiopathic membranous nephropathy. cytoplasmic cytokine analysis","volume":"91","author":"Hirayama","year":"2002","journal-title":"Nephron"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1038\/nature22329","article-title":"Dominant protection from HLA-linked autoimmunity by antigen-specific regulatory T cells","volume":"545","author":"Ooi","year":"2017","journal-title":"Nature"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20031579","article-title":"Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis","volume":"199","author":"Viglietta","year":"2004","journal-title":"J Exp Med"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20040165","article-title":"Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy","volume":"200","author":"Ehrenstein","year":"2004","journal-title":"J Exp Med"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1016\/S0896-8411(03)00121-5","article-title":"Quantification of regulatory T cells in patients with systemic lupus erythematosus","volume":"21","author":"Crispin","year":"2003","journal-title":"J Autoimmun"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1172\/JCI0213605","article-title":"Multiple immuno-regulatory defects in type-1 diabetes","volume":"109","author":"Kukreja","year":"2002","journal-title":"J Clin Invest"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2016.09.048","article-title":"Membranous nephropathy: integrating basic science into improved clinical management","volume":"91","author":"Cattran","year":"2017","journal-title":"Kidney Int"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.574997","article-title":"Th17-immune response in patients with membranous nephropathy is associated with thrombosis and relapses","volume":"11","author":"Cremoni","year":"2020","journal-title":"Front Immunol"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.26717\/BJSTR.2018.07.001579","article-title":"Variation of peripheral Th17\/Treg imbalance in patients with idiopathic membranous nephropathy after cyclosporin a treatment: A prognostic marker of idiopathic membranous nephropathy","volume":"7","author":"Dan","year":"2018","journal-title":"BioMed J Sci Tech Res"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.683330","article-title":"Single-cell profiling reveals transcriptional signatures and cell-cell crosstalk in anti-PLA2R positive idiopathic membranous nephropathy patients","volume":"12","author":"Xu","year":"2021","journal-title":"Front Immunol"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2021060784","article-title":"Molecular characterization of membranous nephropathy","volume":"33","author":"Sealfon","year":"2022","journal-title":"J Am Soc Nephrol"},{"key":"B119","doi-asserted-by":"publisher","first-page":"e104354","DOI":"10.1371\/journal.pone.0104354","article-title":"Circulating TNF receptors are significant prognostic biomarkers for idiopathic membranous nephropathy","volume":"9","author":"Lee","year":"2014","journal-title":"PloS One"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199811123392007","article-title":"Pathophysiology of progressive nephropathies","volume":"339","author":"Remuzzi","year":"1998","journal-title":"N Engl J Med"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.22881","article-title":"Inhibition of tumor necrosis factor signaling attenuates renal immune cell infiltration in experimental membranous nephropathy","volume":"8","author":"Huang","year":"2017","journal-title":"Oncotarget"},{"key":"B122","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1177\/147323001103900111","article-title":"Correlation between b lymphocyte abnormality and disease activity in patients with idiopathic membranous nephropathy","volume":"39","author":"Wang","year":"2011","journal-title":"J Int Med Res"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201445036","article-title":"B cells expressing IFN-\u03b3 suppress treg-cell differentiation and promote autoimmune experimental arthritis","volume":"45","author":"Olalekan","year":"2015","journal-title":"Eur J Immunol"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2016.02.014","article-title":"New insights into immune mechanisms underlying response to rituximab in patients with membranous nephropathy: A prospective study and a review of the literature","volume":"15","author":"Roccatello","year":"2016","journal-title":"Autoimmun Rev"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2020.03.023","article-title":"Regulatory b cells are reduced and correlate with disease activity in primary membranous nephropathy","volume":"5","author":"Ramachandran","year":"2020","journal-title":"Kidney Int Rep"},{"key":"B126","doi-asserted-by":"publisher","first-page":"7638365","DOI":"10.1155\/2020\/7638365","article-title":"The potential role of regulatory b cells in idiopathic membranous nephropathy","volume":"2020","author":"Dong","year":"2020","journal-title":"J Immunol Res"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00387","article-title":"The landscape and prognosis potential of the T-cell repertoire in membranous nephropathy","volume":"11","author":"Zhang","year":"2020","journal-title":"Front Immunol"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.635326","article-title":"The diagnostic and prognostic potential of the b-cell repertoire in membranous nephropathy","volume":"12","author":"Su","year":"2021","journal-title":"Front Immunol"},{"key":"B129","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.135.4.2400","article-title":"Characterization of antigens and antibody specificities involved in heymann nephritis","volume":"135","author":"Kamata","year":"1985","journal-title":"J Immunol"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1084\/jem.188.7.1353","article-title":"Inhibition of complement regulation is key to the pathogenesis of active heymann nephritis","volume":"188","author":"Schiller","year":"1998","journal-title":"J Exp Med"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2001.00476.x","article-title":"No complement receptor 1 stumps on podocytes in human glomerulopathies","volume":"59","author":"Moll","year":"2001","journal-title":"Kidney Int"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2020.01.018","article-title":"Proteomic analysis of complement proteins in membranous nephropathy","volume":"5","author":"Ravindran","year":"2020","journal-title":"Kidney Int Rep"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1172\/JCI109987","article-title":"A new role for complement in experimental membranous nephropathy in rats","volume":"66","author":"Salant","year":"1980","journal-title":"J Clin Invest"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2003.00188.x","article-title":"Rat glomerular epithelial cells produce and bear factor h on their surface that is up-regulated under complement attack","volume":"64","author":"Ren","year":"2003","journal-title":"Kidney Int"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2021101384","article-title":"Complement C3a and C3a receptor activation mediates podocyte injuries in the mechanism of primary membranous nephropathy","volume":"33","author":"Gao","year":"2022","journal-title":"J Am Soc Nephrol"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1995.224","article-title":"Active heymann nephritis in complement component C6 deficient rats","volume":"47","author":"Leenaerts","year":"1995","journal-title":"Kidney Int"},{"key":"B137","article-title":"Depletion of C6 prevents development of proteinuria in experimental membranous nephropathy in rats","volume":"135","author":"Baker","year":"1989","journal-title":"Am J Pathol"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00437.2004","article-title":"Experimental membranous nephropathy redux","volume":"289","author":"Cybulsky","year":"2005","journal-title":"Am J Physiol Renal Physiol"},{"key":"B139","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/modpathol.2012.237","article-title":"IgG subclass staining in renal biopsies with membranous glomerulonephritis indicates subclass switch during disease progression","volume":"26","author":"Huang","year":"2013","journal-title":"Mod Pathol"},{"key":"B140","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1038\/ki.2012.209","article-title":"Enhanced expression of the m-type phospholipase A2 receptor in glomeruli correlates with serum receptor antibodies in primary membranous nephropathy","volume":"82","author":"Hoxha","year":"2012","journal-title":"Kidney Int"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1016\/j.semnephrol.2013.08.004","article-title":"The role of complement in membranous nephropathy","volume":"33","author":"Ma","year":"2013","journal-title":"Semin Nephrol"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1159\/000508665","article-title":"Effect of glomerular mannose-binding lectin deposition on the prognosis of idiopathic membranous nephropathy","volume":"45","author":"Zhang","year":"2020","journal-title":"Kidney Blood Press Res"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfx235","article-title":"Glomerular mannose-binding lectin deposition in intrinsic antigen-related membranous nephropathy","volume":"33","author":"Hayashi","year":"2017","journal-title":"Nephrol Dial Transpl"},{"key":"B144","doi-asserted-by":"publisher","first-page":"3539","DOI":"10.1681\/ASN.2015101155","article-title":"Phospholipase A2 receptor\u2013related membranous nephropathy and mannan-binding lectin deficiency","volume":"27","author":"Bally","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.16631020","article-title":"Limited significance of antifactor h antibodies in patients with membranous nephropathy","volume":"16","author":"Sethi","year":"2021","journal-title":"Clin J Am Soc Nephrol"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01433","article-title":"Alternative pathway is essential for glomerular complement activation and proteinuria in a mouse model of membranous nephropathy","volume":"9","author":"Luo","year":"2018","journal-title":"Front Immunol"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V1081689","article-title":"Reduction in glomerular heparan sulfate correlates with complement deposition and albuminuria in active heymann nephritis","volume":"10","author":"Raats","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1993.67","article-title":"Distribution of GBM heparan sulfate proteoglycan core protein and side chains in human glomerular diseases","volume":"43","author":"Van Den Born","year":"1993","journal-title":"Kidney Int"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1201751","article-title":"Tissue-specific host recognition by complement factor h is mediated by differential activities of its glycosaminoglycan-binding regions","volume":"190","author":"Clark","year":"2013","journal-title":"J Immunol"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M801918200","article-title":"Aberrant interaction between Parkinson disease-associated mutant UCH-L1 and the lysosomal receptor for chaperone-mediated autophagy","volume":"283","author":"Kabuta","year":"2008","journal-title":"J Biol Chem"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1172\/JCI39492","article-title":"Autophagy influences glomerular disease susceptibility and maintains podocyte homeostasis in aging mice","volume":"120","author":"Hartleben","year":"2010","journal-title":"J Clin Invest"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1002\/path.2446","article-title":"A new role for the neuronal ubiquitin c-terminal hydrolase-L1 (UCH-L1) in podocyte process formation and podocyte injury in human glomerulopathies","volume":"217","author":"Meyer-Schwesinger","year":"2009","journal-title":"J Pathol"},{"key":"B153","doi-asserted-by":"publisher","first-page":"e21170","DOI":"10.1096\/fj.202001143R","article-title":"sPLA2-IB and PLA2R mediate insufficient autophagy and contribute to podocyte injury in idiopathic membranous nephropathy by activation of the p38MAPK\/mTOR\/ULK1(ser757) signaling pathway","volume":"35","author":"Yang","year":"2021","journal-title":"FASEB J"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2020.06.031","article-title":"Fumarate modulates phospholipase A2 receptor autoimmunity-induced podocyte injury in membranous nephropathy","volume":"99","author":"Jo","year":"2021","journal-title":"Kidney Int"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2015030302","article-title":"Metabolomics reveals a key role for fumarate in mediating the effects of NADPH oxidase 4 in diabetic kidney disease","volume":"27","author":"You","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1111\/eci.12292","article-title":"Serum with phospholipase A2 receptor autoantibodies interferes with podocyte adhesion to collagen","volume":"44","author":"\u0160koberne","year":"2014","journal-title":"Eur J Clin Invest"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2019-232896","article-title":"Ofatumumab for multirelapsing membranous nephropathy complicated by rituximab-induced serum-sickness","volume":"13","author":"Podest\u00e0","year":"2020","journal-title":"BMJ Case Rep"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.03069","article-title":"Neutralizing anti-rituximab antibodies and relapse in membranous nephropathy treated with rituximab","volume":"10","author":"Boyer-Suavet","year":"2019","journal-title":"Front Immunol"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-016-0451-1","article-title":"A review of obinutuzumab (GA101), a novel type II anti-CD20 monoclonal antibody, for the treatment of patients with b-cell malignancies","volume":"34","author":"Tobinai","year":"2017","journal-title":"Adv Ther"},{"key":"B160","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1136\/annrheumdis-2020-eular.2983","article-title":"Alternative renal response definitions in a randomized, controlled trial of obinutuzumab for proliferative lupus nephritis [abstract]","volume":"72","author":"Amoura","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2001180","article-title":"Two-year, randomized, controlled trial of belimumab in lupus nephritis","volume":"383","author":"Furie","year":"2020","journal-title":"N Engl J Med"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2107725","article-title":"CD19-targeted CAR T cells in refractory systemic lupus erythematosus","volume":"385","author":"Mougiakakos","year":"2021","journal-title":"N Engl J Med"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.3410\/f.742323959.793595617","article-title":"Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus","volume":"28","author":"Mackensen","year":"2022","journal-title":"Nat Med"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1159\/000515087","article-title":"Bortezomib treatment for refractory PLA2R-positive membranous nephropathy","volume":"1","author":"Geara","year":"2021","journal-title":"Glomerular Dis"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1007\/s40620-013-0028-x","article-title":"Bortezomib therapy for nephrotic syndrome due to idiopathic membranous nephropathy","volume":"27","author":"Hartono","year":"2014","journal-title":"J Nephrol"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.1111\/petr.12873","article-title":"Bortezomib in the treatment of antibody-mediated rejection in pediatric kidney transplant recipients: A multicenter Midwest pediatric nephrology consortium study","volume":"21","author":"Kizilbash","year":"2017","journal-title":"Pediatr Transpl"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.15881","article-title":"Reversing donor-specific antibody responses and antibody-mediated rejection with bortezomib and belatacept in mice and kidney transplant recipients","volume":"20","author":"Jain","year":"2020","journal-title":"Am J Transpl"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaf6756","article-title":"Reengineering chimeric antigen receptor T cells for targeted therapy of autoimmune disease","volume":"353","author":"Ellebrecht","year":"2016","journal-title":"Science"},{"key":"B169","doi-asserted-by":"publisher","first-page":"102289","DOI":"10.1016\/j.jaut.2019.05.017","article-title":"Regulatory T cells engineered with a novel insulin-specific chimeric antigen receptor as a candidate immunotherapy for type 1 diabetes","volume":"103","author":"Tenspolde","year":"2019","journal-title":"J Autoimmun"},{"key":"B170","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/1742-2094-9-112","article-title":"CAR\/FoxP3-engineered T regulatory cells target the CNS and suppress EAE upon intranasal delivery","volume":"9","author":"Fransson","year":"2012","journal-title":"J Neuroinflammation"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2008.02.060","article-title":"Redirection of regulatory T cells with predetermined specificity for the treatment of experimental colitis in mice","volume":"134","author":"Elinav","year":"2008","journal-title":"Gastroenterology"},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20020394","article-title":"Infectious tolerance: human CD25(+) regulatory T cells convey suppressor activity to conventional CD4(+) T helper cells","volume":"196","author":"Jonuleit","year":"2002","journal-title":"J Exp Med"},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20080308","article-title":"CD4+ FoxP3+ regulatory T cells confer infectious tolerance in a TGF-beta-dependent manner","volume":"205","author":"Andersson","year":"2008","journal-title":"J Exp Med"},{"key":"B174","doi-asserted-by":"publisher","first-page":"7676","DOI":"10.1038\/s41598-021-87102-4","article-title":"Life-extended glycosylated IL-2 promotes treg induction and suppression of autoimmunity","volume":"11","author":"Ottolenghi","year":"2021","journal-title":"Sci Rep"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1467-x","article-title":"Opposing T cell responses in experimental autoimmune encephalomyelitis","volume":"572","author":"Saligrama","year":"2019","journal-title":"Nature"},{"key":"B176","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1016\/j.cell.2021.02.027","article-title":"Follicular regulatory T cells produce neuritin to regulate b cells","volume":"184","author":"Gonzalez-Figueroa","year":"2021","journal-title":"Cell"},{"key":"B177","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2018.04.059","article-title":"A multi-layered quantitative In vivo expression atlas of the podocyte unravels kidney disease candidate genes","volume":"23","author":"Rinschen","year":"2018","journal-title":"Cell Rep"},{"key":"B178","doi-asserted-by":"publisher","DOI":"10.1002\/j.1460-2075.1993.tb05878.x","article-title":"Protocadherins: a large family of cadherin-related molecules in central nervous system","volume":"12","author":"Sano","year":"1993","journal-title":"EMBO J"},{"key":"B179","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygeno.2005.04.004","article-title":"Human netrin-G1 isoforms show evidence of differential expression","volume":"86","author":"Meerabux","year":"2005","journal-title":"Genomics"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.1036249\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,10]],"date-time":"2023-03-10T19:12:55Z","timestamp":1678475575000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.1036249\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,2]]},"references-count":179,"alternative-id":["10.3389\/fimmu.2022.1036249"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.1036249","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,2]]},"article-number":"1036249"}}